2024-10-20 - Analysis Report
## HCA Healthcare Inc. (HCA) Stock Analysis Report

**Company Overview:** HCA Healthcare Inc. is a leading provider of healthcare services in the United States.

**1. Performance and Outperformance:**

HCA has significantly outperformed the S&P 500 (VOO) in terms of cumulative returns.  

* **HCA Cumulative Return:** 344.39%
* **S&P 500 (VOO) Cumulative Return:** 137.88%
* **Difference:** 206.51%
* **Relative Outperformance:** 100.0% (meaning HCA is at the highest point of outperformance compared to its historical range against VOO).

**2. Recent Price Movements:**

* **Closing Price:** $415.54
* **5-day Moving Average:** $405.66
* **20-day Moving Average:** $399.02
* **60-day Moving Average:** $385.78

This suggests a short-term upward trend in HCA's stock price, with the current price above all the moving averages.

**3. Technical Indicators:**

* **RSI:** 56.14 (slightly overbought)
* **PPO:** 0.36 (positive, indicating potential upward momentum)
* **Delta_Previous_Relative_Divergence:** 0.69 (positive, suggesting recent outperformance)
* **Expected_Return:** 10.32% (indicating potential for higher returns than S&P 500 over the long term)

The technical indicators point to a moderately positive outlook for HCA. The RSI suggests a slight overbought condition, while the PPO and positive delta suggest strong short-term momentum.

**4. Recent Earnings and Outlook:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-07-29 | 5.6 | $17.49 Billion |
| 2024-05-02 | 6.01 | $17.34 Billion |
| 2023-10-26 | 3.98 | $16.21 Billion |
| 2023-08-02 | 4.35 | $15.86 Billion |
| 2024-07-29 | 4.35 | $15.86 Billion |

HCA's recent earnings have been consistently strong, demonstrating solid growth in both EPS and revenue. While the most recent earnings (2024-07-29) were not yet accompanied by analyst expectations, the previous earnings results were mostly in line with or exceeding analysts' predictions.

**5. News and Recent Issues:**

**Recent Market Outlook for HCA:** The market outlook for HCA remains positive, with analysts expecting continued growth in the healthcare sector and a strong demand for HCA's services.

**Analyst Opinions and Performance Highlights:** 

* **FINBOLD:**  Analysts at FINBOLD have issued a "Buy" rating on HCA, citing strong earnings performance and a favorable market environment for the healthcare sector.
* **Other Analysts:** Several other analysts have also issued positive ratings on HCA, citing its strong financial position and consistent growth in revenue and earnings.

**6. Overall Analysis:**

HCA's stock has significantly outperformed the S&P 500 over the long term. The company's recent earnings performance has been strong, and analysts are optimistic about its future prospects. Technical indicators suggest a positive short-term trend, and HCA's expected long-term return is significantly higher than the S&P 500. 

**7. Conclusion:**

HCA Healthcare Inc. presents an attractive investment opportunity for investors seeking exposure to the healthcare sector. Its strong performance, consistent growth, and positive technical indicators suggest potential for continued outperformance in the future. 
